2.1(top 8%)
Impact Factor
2.3(top 8%)
extended IF
588(top 1%)
H-Index
12K
authors
130.3K
papers
2.9M
citations
14K
citing journals
293.7K
citing authors

Most Cited Articles of Journal of Clinical Oncology

TitleYearCitations
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial19974.5K
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure19934.2K
Final version of 2009 AJCC melanoma staging and classification20093.5K
Revised response criteria for malignant lymphoma20073.5K
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer20003.1K
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States20083.1K
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group19992.9K
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group20072.9K
Supervised risk predictor of breast cancer based on intrinsic subtypes20092.8K
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world20062.8K
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer20082.7K
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer20072.6K
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients20012.6K
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer20082.6K
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update20132.6K
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]20032.5K
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group20102.5K
Human papillomavirus and rising oropharyngeal cancer incidence in the United States20112.4K
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study20042.4K
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification20142.3K
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study20082.3K
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma20032.3K
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program19982.3K
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease19992.3K
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations20132.2K